Probability of attaining a state of inactive disease and (number of subjects still in the cohort with persistent active disease) | ||||||
---|---|---|---|---|---|---|
ILAR category | Number* | Within 1 year | Within 2 years | Within 3 years | Within 4 years | Within 5 years |
Whole cohort | 1086 | 0.449 (572) | 0.777 (180) | 0.847 (85) | 0.916 (26) | 0.952 (6) |
Systemic arthritis | 74 | 0.453 (39) | 0.708 (19) | 0.727 (11) | 0.851 (6) | 0.851 (3) |
Oligoarthritis | 410 | 0.606 (155) | 0.864 (43) | 0.917 (15) | 0.961 (3) | 0.961 (1) |
RF-negative Polyarthritis | 232 | 0.341 (148) | 0.709 (51) | 0.780 (30) | 0.880 (11) | 0.966 (1) |
RF-positive Polyarthritis | 46 | 0.221 (34) | 0.483 (17) | 0.666 (6) | 0.791 (3) | 0.930 (1) |
Psoriatic arthritis | 63 | 0.459 (32) | 0.907 (4) | 0.930 (2) | 0.930 (1) | 1.00 (0) |
Enthesitis-related arthritis | 153 | 0.336 (96) | 0.724 (28) | 0.872 (11) | 0.925 (1) | 0.925 (0) |
Undifferentiated | 108 | 0.33 (68) | 0.784 (18) | 0.837 (9) | 0.888 (2) | 1.00 (0) |
*Number of patients who contributed data for this analysis.
ILAR, International League of Associations for Rheumatology.